Seer appoints Meeta Gulyani to Board of Directors; brings life sciences industry experience from Merck KGaA

Seer, Inc.

Appointed Meeta Gulyani as Class III director with term expiring at 2023 annual meeting.
Gulyani is EVP, Head of Strategy, Business Development & Transformation for Merck KGaA's Life Science business (MilliporeSigma).
Received initial stock option for 30,000 shares vesting monthly over 3 years; annual cash retainer of $40,000.
Board expanded from nine to ten directors effective November 29, 2021.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Meeta Gulyani

Director

SEER · Seer, Inc.

Effective: 2021-11-29
Filed: November 29, 2021, 6:59 PM ET

Contemporaneously, Meeta Gulyani was appointed to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Meeta Gulyani was appointed as Director at Seer, Inc..

Action: appointed
Role: Director

Exact text from the filing

Contemporaneously, Meeta Gulyani was appointed to the Board.

View on SEC.gov

Seer, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-21-024168

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.